September 19, 2017 7:32 PM ET

Biotechnology

Company Overview of Pelican Therapeutics, Inc.

Key Executives for Pelican Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Josiah C. Hornblower 17 RelationshipsCo-Founder, Acting Chief Executive Officer and Director--
Jeffrey Alan Wolf J.D.40 RelationshipsCo-Founder and Director54

Pelican Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Josiah C. Hornblower 17 RelationshipsShattuck Labs, Inc.--
Jeffrey Alan Wolf J.D. 40 RelationshipsHeat Biologics, Inc.54
Taylor H. Schreiber M.D., Ph.D. 13 RelationshipsHeat Biologics, Inc.37
Laurence A. Turka M.D. 49 RelationshipsCaladrius Biosciences, Inc.--
Edward B. Smith III 13 RelationshipsHeat Biologics, Inc.42
View All Board Members

Pelican Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board M.D., Ph.D.Taylor H. Schreiber13 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
390.3K
Bonus
235.6K
Total Short Term Compensation
484.8K
Total Value of Options
18.3M
Compensation as of Fiscal Year
Pelican Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

C. Geoffrey McDonough Resigns from the Board of Directors of PTC Therapeutics, Inc
September 18, 2017 9:18 PM ET
Bioasis Technologies Inc. Announces Management Changes
September 18, 2017 4:05 PM ET
Voyager Therapeutics, Inc. Names Matthew P. Ottmer as Chief Operating Officer
September 18, 2017 1:00 PM ET
Achaogen Appoints Liz Bhatt as Chief Business Officer
September 18, 2017 12:55 PM ET
Recros Medica, Inc. Appoints Thomas A. Albright as President and CEO
September 18, 2017 12:53 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Pelican Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.